Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
4-[F]-Fluorophenylglyoxal ([F]-FPG) is a novel arginine selective bioconjugation reagent for native protein F-labeling. Here, we report the automated radiosynthesis of [F]-FPG on a Scintomics GRP module. The radiochemical preparation was performed in a one-pot, two-step process using a DMSO-resistant cassette system. A cartridge-based purification method was developed to purify [F]-FPG without HPLC. The [F]-FPG was prepared in nondecay corrected (n.d.c.) radiochemical yields (RCYs) of 27 ± 2% ( = 5) in 56 min from the end of the bombardment until formulation. The molar activities of [F]-FPG were 147 ± 70 GBq/μmol ( = 5). The 4-[F]-FPG was then conjugated with interleukin-4 (IL-4) in n.d.c. 26 ± 2% RCYs ( = 3) from [F]-FPG with molar activities of 24 ± 4 GBq/μmol ( = 3). [F]-FPG-IL4 exhibited >95% stability in either PBS (4 h) or human serum (2 h) in vitro. [F]-FPG-IL4 showed specific uptake by the PHA-activated Jurkat cells. The in vivo biodistribution and pharmacokinetics of [F]-FPG-IL4 were evaluated in healthy Balb/c mice with PET imaging.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120570 | PMC |
| http://dx.doi.org/10.1021/acsomega.5c01278 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background Fentanyl is a potent synthetic opioid widely used for pain management and anesthesia, but the high prevalence of its misuse and its key contribution to overdose fatalities in the United States have made it a major drug of concern. Although fentanyl's onset, duration, and toxicity depend on its pharmacokinetics and specific tissue distribution, most studies have focused primarily on plasma concentrations, leaving its distribution in critical tissues largely unexplored (this knowledge gap limits our understanding of fentanyl's clinical effects, tissue accumulation, and the factors influencing its efficacy and safety). Here, we report the radiosynthesis of [ C]fentanyl for PET imaging and present a preliminary whole-body pharmacokinetic study in rodents.
View Article and Find Full Text PDFAutomated production of radiotracer [F]FZTA for imaging sphingosine-1-phosphate receptor 1 (S1PR1) in human.
Appl Radiat Isot
August 2025
Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri, 63110, United States. Electronic address:
We report a reliable fully automated procedure to produce a promising F-18 labeled sphingosine-1-phosphate receptor 1 (S1PR1) PET ligand, 3-((2-fluoro-4-(5-(4-(2-(fluoro-F)ethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl) (methyl)amino)propan-1-ol ([F]FZTA) on the GE TRACERlab FX2N module, using a one-pot two-step procedure following current Good Manufacturing Practices (cGMP). The MOM-protected precursor 1 was fluorinated with no-carrier-added [F]KF, catalyzed by Kryptofix 222 under heat, to afford the intermediate [F]2. After deprotecting the MOM-group on [F]2 under acidic condition, the reaction was quenched into a neutralized solution, which was then loaded on semi-preparative HPLC for purification.
View Article and Find Full Text PDFAutomated Radiosynthesis of [F]FMeNER-D Using the Simplified One-Pot F-Fluoromethylation Method.
J Labelled Comp Radiopharm
July 2025
Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
(S,S)-2-(α-(2-[F]Fluoro[dideutero]methoxyphenoxy)benzyl)morpholine ([F]FMeNER-D), which is used to image the norepinephrine transporter in the brain via positron emission tomography (PET), is typically radiosynthesized by O-fluoromethylating norethylreboxetine (NER) with [F]bromofluoromethane-d using a fully automated F-labeling synthesizer with a two-pot unit. We simplified the automated radiosynthesis of [F]FMeNER-D through the use of a straightforward one-pot method to prepare [F]fluoromethyl-d-tosylate as the fluoromethylating agent (avoiding the need to azeotropically dry [F]F in advance), which was then reacted with NER. The reaction conditions were optimized, with [F]FMeNER-D synthesized using an F-labeling synthesizer equipped with a one-pot unit.
View Article and Find Full Text PDFBackground: Infections pose a significant risk to immunocompromised individuals, and accurate, efficient diagnosis remain challenging. Current imaging methods like MRI and FDG PET lack pathogen specificity which complicate diagnosis and lead to overuse of antibiotics. Recent data shows that [F]fluoromannitol ([F]FMtl) is sensitive and specific to infection in vivo by exploiting the pathogen-specific mannitol transporter.
View Article and Find Full Text PDFProduction of At and automated radiosynthesis of [At]MABG via electrophilic astatodesilylation.
EJNMMI Radiopharm Chem
August 2025
Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Background: [At]m-Astatobenzylguanidine ([At]MABG) has demonstrated potent antitumor efficacy in preclinical models of malignant neuroendocrine tumours including neuroblastoma and pheochromocytoma/paraganglioma. The high linear energy transfer and short tissue penetration range of alpha particles enable highly localized cytotoxic effects, potentially overcoming therapeutic limitations associated with conventional beta-emitting radiopharmaceuticals. However, under clinical-scale (i.
View Article and Find Full Text PDF